Article
Case Report: Disseminated, rifampicin resistant Mycobacterium bovis (BCG) infection in an immunocompromised child
2020-10-15
Abstract excerpt
<h4>Background: </h4> Bacillus Calmette–Guérin (BCG) is a live-attenuated vaccine used world-wide for prevention of tuberculosis disease. In some immunocompromised hosts it has the potential to cause disease. As with other members of the M. tuberculosis complex it has the potential for acquiring drug resistance. <h4>Methods: </h4>: We reviewed 10 years of paediatric clinical BCG strains referred to our clinical...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bdcd4fef-b014-5044-9d0c-695804502249
- DOI
- 10.12688/wellcomeopenres.16280.1
